Vivet Therapeutics
FranceEntry
2017
Hold
9yr
Status
Active
Who owns Vivet Therapeutics?
Vivet Therapeutics is currently owned by Columbus Venture Partners through Columbus Innvierte Life Science Fund I (2016 vintage), since 2017. Across its history, Vivet Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Columbus Venture PartnersColumbus Innvierte Life Science Fund I · 2016 · Life Sciences VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2017 · present
Ysios Capital PartnersActive
2017 · present(9yr) · Ysios BioFund II Innvierte · 2016 · Life Sciences VC
More from Columbus Innvierte Life Science Fund I
Other portfolio companies in the same fund.
United States
Spain
More PE-backed in Biotech
Comparable biotech deals from other GPs.
UK
Track Vivet Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Vivet Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue